期刊文献+

血管紧张素Ⅱ对大鼠血管外膜成纤维细胞骨桥蛋白表达的影响 被引量:1

Effects of Angiotensin Ⅱ on the Expression of Osteopontin in Rat Vascular Adventitial Fibroblasts
下载PDF
导出
摘要 目的研究血管紧张素Ⅱ对培养的大鼠胸主动脉外膜成纤维细胞骨桥蛋白表达的影响。方法大鼠外膜成纤维细胞被随机分为对照组、血管紧张素Ⅱ不同浓度(10-8、10-7、10-6和10-5mol/L)和时间(6h、12h和24h)干预组及血管紧张素Ⅱ加AT1受体拮抗剂氯沙坦和/或AT2受体拮抗剂PD123319干预组,用RT-PCR及Western blotting技术结合光密度扫描分析,观察血管紧张素Ⅱ对培养的大鼠胸主动脉外膜成纤维细胞骨桥蛋白表达的影响。结果血管紧张素Ⅱ10-6mol/L明显刺激外膜成纤维细胞骨桥蛋白的表达,6h、12h和24h桥蛋白较对照组分别升高65.43%、97.03%和105.11%(P<0.05);而24h阴性对照无明显变化。不同浓度的血管紧张素Ⅱ均可诱导骨桥蛋白表达,10-8、10-7、10-6和10-5mol/L管紧张素Ⅱ孵育后分别升高了70.46%、97.37%、123.10%和147.59%(P<0.01)。在血管紧张素Ⅱ刺激前1h分别加入氯沙坦(10-5mol/L)、PD123319(10mmol/L)、氯沙坦(10-5mol/L)+PD123319(10mmol/L),共同孵育12h后,其抑制率分别为58.9%、0.92%和59.7%。Western blotting分析,12h不同剂量血管紧张素Ⅱ干预组(10-8、10-7、10-6和10-5mol/L)骨桥蛋白量较对照组分别提高了50.68%、63.03%和69.86%(P<0.05),氯沙坦明显抑制血管紧张素Ⅱ刺激的骨桥蛋白表达,抑制率达到61.7%(P<0.05),而PD123319作用后抑制作用不明显,抑制率仅为0.85%(P>0.05)。结论血管紧张素Ⅱ能在基因和蛋白水平上刺激大鼠外膜成纤维细胞骨桥蛋白的表达,此作用可能是通过AT1受体介导。 Aim To explore the function of angiotensin Ⅱ (AngⅡ) in promoting osteopontin gene expression and protein synthsis of rat vascular adventitial fibroblasts. Methods Cultured cells were incubated with 1 different concentration of AngⅡ for different hours and AngⅡ plus AT1 receptor blocker,losartan or/and AT2 receptor blocker,PD123319. Then RT-PCR and WesternBlotting analysis were used to observe the effect of AngⅡ on osteopontin gene expression of rat vascular adventitial fibroblasts. Results AngⅡ(10-6 mol/L)o...
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第12期961-964,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 血管紧张素Ⅱ 外膜成纤维细胞 骨桥蛋白 氯沙坦 血管重塑 Angiotensin Ⅱ Vascular Adventitial Fibroblasts Osteopontin Losartan Vascular Remodeling
  • 相关文献

参考文献6

  • 1Van Vickle-Chavez SJ,Tung W,SAbsi TS,et al.Temporal changes in mouse aortic wall gene expression during the development of elastase-in-duced abdominal aortic aneurysms[].Journal of Vascular Surgery.2006
  • 2Li G,Oparil S,Kelpke SS,et al.Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro[].Circulation.2002
  • 3KIM DK,,HUH JE,LEE SH,et al.Angiotensin II stimulates proliferation of adventitial fibroblasts cultured from rat aortic ex-plants[].Journal of Korean Medical Science.1999
  • 4Tsuruda T,Kato J,Hatakeyama K,et al.Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin Ⅱ-induced hypertensive rats[].Cardiovascular Research.2005
  • 5Golledge,J,McCann,M,Mangan,S,Lam,A,Karan,M.Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis[].Stroke.2004
  • 6Sun,A. J.,Gao,P. J.,Liu,J. J.,Ji,K. D.,Zhu,D. L.Identification of genes related to cell phenotypic transition by differential display analysis[].Acta Physiologica Sinica.2001

同被引文献24

  • 1John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis [J]. Pathol Oncol Res, 2001, 7(1): 14-23.
  • 2Denhardt DT, Noda M, O'Regan AW, et al. Osteopontin as a means to cope with environmental insults: Regula- tion of inflammation, tissue remodeling, and cell survival [J]. J Clin Invest, 2001, 107(9): 1055-1061.
  • 3Reinhoh FP, I-Iuhenby K, Oldberg A, et al. Osteopontin-- a possible anchor of osteoclasts to bone[J]. Proc Natl Acad Sci U S A, 1990, 87(12):4473-4475.
  • 4Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II : Role of an intracardiac renin-angiotensin system[J]. Annu Rev Physiol, 1992, 54:227-241.
  • 5Lynn H, Kwok T, Wong SY, et al. Angiotensin conver- ting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese[J]. Bone, 2006, 38 (4): 584-588.
  • 6Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blo- ckers is associated with a reduced fracture risk: A na- tionwide case-control study[J]. J Hypertens, 2006, 24 (3) : 581-589.
  • 7Uemura T, Nemoto A, Liu YK, et al. Osteopontin in- volvement in bone remodeling and its effects on in vivo osteogenie potential of bone marrow-derived osteoblasts/ porous hydroxyapatite constructs[J]. Mater Sei Eng: C, 2001, 17 (1/2) : 33-36.
  • 8Huang W, Carlsen B, Rudkin G, et al. Osteopontin is a negative regulator of proliferation and differentiation in MC3T3-E1 pre-osteoblastic cells[J]. Bone, 2004, 34(5): 799-808.
  • 9Boskey AL, Maresca M, Ullrich W, et al. Osteopontin- hydroxyapatite interactions in vitro: Inhibition of hydrox- yapatite formation and growth in a gelatin-gel[J]. Bone Miner, 1993, 22(2) : 147-159.
  • 10Hunter GK, Hausehka PV, Poole AR, et al. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins[J]. Bioehem J, 1996, 317(Pt 1):59-64.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部